[
  {
    "ts": null,
    "headline": "Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment",
    "summary": "Merck (NYSE:MRK) recently presented promising results from the Phase 3 ZENITH trial for its drug WINREVAIR, but the company's stock performance over the past month tells a different story, declining by 3.3%. This decrease in share price coincides with broader market trends, including steep losses in major indices due to looming tariffs and economic uncertainty, which have also impacted Merck's peer companies. Despite the positive drug trial outcomes and regulatory progress with CAPVAXIVE and...",
    "url": "https://finnhub.io/api/news?id=4a4431e6b019503d9d5b2ac5f6983eaf1c93eb047e0c5a8432ba5e92789c3c4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743442301,
      "headline": "Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment",
      "id": 133632987,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (NYSE:MRK) recently presented promising results from the Phase 3 ZENITH trial for its drug WINREVAIR, but the company's stock performance over the past month tells a different story, declining by 3.3%. This decrease in share price coincides with broader market trends, including steep losses in major indices due to looming tariffs and economic uncertainty, which have also impacted Merck's peer companies. Despite the positive drug trial outcomes and regulatory progress with CAPVAXIVE and...",
      "url": "https://finnhub.io/api/news?id=4a4431e6b019503d9d5b2ac5f6983eaf1c93eb047e0c5a8432ba5e92789c3c4f"
    }
  },
  {
    "ts": null,
    "headline": "Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?",
    "summary": "AstraZeneca said Monday its experimental pill lowered \"bad\" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks.",
    "url": "https://finnhub.io/api/news?id=28a26f90e943889317642c2b0c0676b9cd4e9c665cbe123f60b6ac1ce77b0eab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743438127,
      "headline": "Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?",
      "id": 133627819,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "AstraZeneca said Monday its experimental pill lowered \"bad\" LDL cholesterol by 51%. But AstraZeneca stock fell in line with pharma stocks.",
      "url": "https://finnhub.io/api/news?id=28a26f90e943889317642c2b0c0676b9cd4e9c665cbe123f60b6ac1ce77b0eab"
    }
  },
  {
    "ts": null,
    "headline": "WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial",
    "summary": "RAHWAY, N.J., March 31, 2025--WINREVAIR reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for PAH by 76% vs. placebo in ZENITH trial.",
    "url": "https://finnhub.io/api/news?id=6c270f05a2f521da494d82f21c6191bf9966982baa2746444c835dc1a53e00a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743429600,
      "headline": "WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial",
      "id": 133627820,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., March 31, 2025--WINREVAIR reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for PAH by 76% vs. placebo in ZENITH trial.",
      "url": "https://finnhub.io/api/news?id=6c270f05a2f521da494d82f21c6191bf9966982baa2746444c835dc1a53e00a2"
    }
  },
  {
    "ts": null,
    "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK",
    "summary": "NEW YORK, March 31, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. . Such investors are advised to contact Danielle Peyton at...",
    "url": "https://finnhub.io/api/news?id=d439998d54cd94f688ce8b52a5ba368663d527d09ea965a09f2c778ca780898d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743425052,
      "headline": "Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK",
      "id": 133627323,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 31, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. . Such investors are advised to contact Danielle Peyton at...",
      "url": "https://finnhub.io/api/news?id=d439998d54cd94f688ce8b52a5ba368663d527d09ea965a09f2c778ca780898d"
    }
  },
  {
    "ts": null,
    "headline": "Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm",
    "summary": "NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . ...",
    "url": "https://finnhub.io/api/news?id=d5efbd5fdf7b6174a72106400f443943214c7deb05571b29b615fb78f7d3bcc6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743399984,
      "headline": "Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm",
      "id": 133624430,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . ...",
      "url": "https://finnhub.io/api/news?id=d5efbd5fdf7b6174a72106400f443943214c7deb05571b29b615fb78f7d3bcc6"
    }
  }
]